Skip to content
10-Q

Quarterly Report

OMNI BIO PHARMACEUTICAL, INC.

0001437749-13-014726

← back to feed
Filed
Nov 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Oct 31, 2013 38.2M sh
Capex Q2 2013 · Sep 30, 2013 $7.42K
Operating Cash Flow Q2 2013 · Sep 30, 2013 −$9.38M
Operating Cash Flow Q2 2013 · Sep 30, 2012 −$864.63K
Stockholders Equity Q2 2013 · Sep 30, 2013 −$192.98K
Stockholders Equity Q2 2013 · Mar 31, 2013 −$604.66K
Current Liabilities Q2 2013 · Sep 30, 2013 $58.69K
Current Liabilities Q2 2013 · Mar 31, 2013 $123.51K
Total Liabilities Q2 2013 · Sep 30, 2013 $1.34M
Total Liabilities Q2 2013 · Mar 31, 2013 $1.3M
Current Assets Q2 2013 · Sep 30, 2013 $886.75K
Current Assets Q2 2013 · Mar 31, 2013 $384.99K
Total Assets Q2 2013 · Sep 30, 2013 $1.14M
Total Assets Q2 2013 · Mar 31, 2013 $699.05K
Sga Expense Q2 2013 · Sep 30, 2013 $28.69M
Sga Expense Q2 2013 · Sep 30, 2012 $1.1M
Sga Expense Q2 2013 · Sep 30, 2012 $2.22M
Rd Expense Q2 2013 · Sep 30, 2013 $2.53M
Rd Expense Q2 2013 · Sep 30, 2012 $127.5K
Rd Expense Q2 2013 · Sep 30, 2012 $149.78K
Net Income Q2 2013 · Sep 30, 2013 −$45.34M
Net Income Q2 2013 · Sep 30, 2012 −$1.33M
Net Income Q2 2013 · Sep 30, 2012 −$2.46M
Operating Income Q2 2013 · Sep 30, 2013 −$37.6M
Operating Income Q2 2013 · Sep 30, 2012 −$1.23M
Operating Income Q2 2013 · Sep 30, 2012 −$2.37M
Cash And Equivalents Q2 2013 · Sep 30, 2012 $680.71K
Cash And Equivalents Q2 2013 · Mar 31, 2012 $133.12K